Alpha Tau to Participate in March Investor Conferences

Company Overview - Alpha Tau Medical Ltd. is an Israeli oncology therapeutics company founded in 2016, focusing on the research, development, and potential commercialization of the Alpha DaRT for treating solid tumors [2]. - The technology behind Alpha DaRT was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University [2]. Product Information - Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is designed for highly potent and conformal alpha-irradiation of solid tumors through the intratumoral delivery of radium-224 impregnated sources [3]. - The therapy aims to destroy tumors by releasing high-energy alpha particles from the decay of radium, which primarily affects the tumor while sparing surrounding healthy tissue due to the short diffusion distance of alpha-emitting atoms [3]. Upcoming Events - CFO Raphi Levy will present at several investor conferences in March 2025, including: - Investor Summit Event on March 11, 2025, from 12:00 PM to 12:30 PM ET [1]. - Oppenheimer 35th Annual Healthcare MedTech & Services Conference on March 17, 2025, from 3:20 PM to 3:50 PM ET [1]. - Sidoti Small Cap Conference on March 19, 2025, from 11:30 AM to 12:00 PM ET [1]. - Mr. Levy will also be available for one-on-one investor meetings at these conferences [1].